BrainsWay Ltd. (NASDAQ:BWAY) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET

Company Participants

Troy Williams – Investor Relations, Life Science Advisors
Hadar Levy – Chief Executive Officer
Ido Marom – Chief Financial Officer

Conference Call Participants

Jeff Cohen – Ladenburg
Steve Lichtman – Oppenheimer
Ram Selvaraju – H.C. Wainwright

Operator

Good morning, everyone. My name is Julie, and I will be your conference operator today. At this time, I would like to welcome everyone to BrainsWay’s First Quarter 2024 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. Thank you.

Troy Williams, Investor Relations from Life Science Advisors. You may begin your conference.

Troy Williams

Thank you, Julie, and welcome to BrainsWay’s first quarter 2024 earnings conference call. With us today are BrainsWay’s Chief Executive Officer, Hadar Levy, and Chief Financial Officer, Ido Marom. The format for today’s call will be a discussion of recent trends and business updates from Hadar, followed by a detailed discussion of the financials. Then we will open up the call for your questions. Earlier today, BrainsWay released financial results for the three months ended March 31, 2024. A copy of the press release is available on the company’s Investor Relations website.

Before I turn over the call to Hadar, I would like to remind you that this conference call, including both management’s prepared remarks and the question-and-answer session may contain projections or other forward-looking statements regarding, among other topics, BrainsWay’s anticipated future operating and financial performance, business plans and prospects and expectations for its products and pipeline, which are all subject to risks and uncertainties, including shifting market conditions as resulting from geopolitical, supply chain and other factors as well as the use of non-GAAP financial information. Additional information regarding these and other risks are available in the company’s earnings release and in its filings with the SEC, including the risk factors section contained in BrainsWay’s Form 20-F.

I would now like to turn the call over to Hadar.

Hadar Levy

Thank you, Troy. Welcome, everyone, and thank you for joining us today. I’m thrilled to report on the continued significant tailwind present throughout our entire business. As such, our outlook for the remainder of 2024 remains highly positive, and we are well positioned to achieve the full year top line growth we anticipated and sustained the previously forecasted profitability momentum and positive cash generation. More on that in a moment. Let me begin though with an overview of our strong results from the first quarter.